SUV39H2 and prostate carcinoma: Expression profile analysis by complementary DNA microarray using a large number of clinical cases also revealed overexpression of SUV39H2 in cervical, bladder, oesophageal and prostate cancers, as well as in osteosarcomas and soft tissue sarcomas (Supplementary Table 1).